<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>CoVex | ResGro CompSysMed</title>
    <link>https://compsysmed.de/tags/covex/</link>
      <atom:link href="https://compsysmed.de/tags/covex/index.xml" rel="self" type="application/rss+xml" />
    <description>CoVex</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 17 Apr 2020 00:14:00 +0200</lastBuildDate>
    <image>
      <url>https://compsysmed.de/img/icon-192.png</url>
      <title>CoVex</title>
      <link>https://compsysmed.de/tags/covex/</link>
    </image>
    
    <item>
      <title>CoVex: Our contribution to the fight against the pandemic</title>
      <link>https://compsysmed.de/post/covex/</link>
      <pubDate>Fri, 17 Apr 2020 00:14:00 +0200</pubDate>
      <guid>https://compsysmed.de/post/covex/</guid>
      <description>&lt;p&gt;To address the current Corona pandemic, the &lt;em&gt;Chair of Experimental Bioinormatics&lt;/em&gt; started a two week &amp;ldquo;ExBio vs. COVID-19&amp;rdquo; hackaton in cooperation with two TUM virologists. The &lt;em&gt;Computational Systems Medicine&lt;/em&gt; recearch group was represented by &lt;a href=&#34;https://compsysmed.de/authors/gihanna_galindez/&#34;&gt;Gihanna Galindez&lt;/a&gt;, &lt;a href=&#34;https://compsysmed.de/authors/tim_kacprowski/&#34;&gt;Tim Kacprowski&lt;/a&gt; and &lt;a href=&#34;https://compsysmed.de/authors/sepideh_sadegh/&#34;&gt;Sepideh Sadegh&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;During the hackaton a first version of the tool &lt;a href=&#34;https://compsysmed.de/softress/covex/&#34;&gt;CoVex&lt;/a&gt; was developed, a drug repurposing tool that integrates virus-human interaction data for SARS-CoV-2 and SARS-CoV. It is now available as &lt;a href=&#34;https://exbio.wzw.tum.de/covex/&#34;&gt;online analysis platform&lt;/a&gt;. Current development updates and research can also be found on the &lt;a href=&#34;https://www.baumbachlab.net/exbio-vs-covid-part-1&#34;&gt;&lt;em&gt;Chair of Experimental Bioinormatics&lt;/em&gt;&lt;/a&gt; website.&lt;/p&gt;
&lt;p&gt;A preprint is now available on &lt;em&gt;&lt;a href=&#34;https://arxiv.org/abs/2004.12420&#34;&gt;arXiv&lt;/a&gt;&lt;/em&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>CoVex</title>
      <link>https://compsysmed.de/softress/covex/</link>
      <pubDate>Sat, 11 Apr 2020 00:00:00 +0200</pubDate>
      <guid>https://compsysmed.de/softress/covex/</guid>
      <description>&lt;p&gt;To address the pandemic of the Coronavirus Disease-2019 (COVID-19), drug repurposing can be a helpful approach since it offers the possibility to find alternative fields of application for already approved drugs. &lt;strong&gt;CoVex&lt;/strong&gt; is the first network and systems medicine online data analysis platform that integrates virus-human interaction data for SARS-CoV-2 and SARS-CoV. It is available as &lt;a href=&#34;https://exbio.wzw.tum.de/covex/&#34;&gt;interactive webtool&lt;/a&gt;. More information and current updates can be found at the &lt;a href=&#34;https://www.baumbachlab.net/exbio-vs-covid-part-1&#34;&gt;CoVex blog&lt;/a&gt; at the &lt;em&gt;Chair of Experimental Bioinformatics&lt;/em&gt; website.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
